摘要:
This invention relates to pharmaceutically acceptable ergoline and tryptamine-based compounds (e.g. analogues, prodrugs and salts thereof). In particular, though not exclusively, the invention relates to formulations and uses of the same as a medicament, alone or in combination with additional pharmaceutically acceptable compounds.